RAYMOND JAMES FINANCIAL INC
Position in TRVI — Trevi Therapeutics, Inc.
CIK 720005
ST. PETERSBURG, FL
Position in TRVI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$30,038,752
+$9,901,189 QoQ
Shares Held
1,610,657
-4.6% QoQ
Ownership
1.13%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#27
of 216 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Derivatives in TRVI
reported options exposure · as of Jun 30, 2026CallValue
$932,500
CallShares
50,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026RAYMOND JAMES FINANCIAL INC holds $1,700,293,661 across 200 Biotechnology names. TRVI ranks #15 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
556,876 | $276,617,014 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
392,799 | $118,244,281 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
172,896 | $107,807,571 | |
| 4 | RPRX |
Royalty Pharma plc
|
1,599,881 | $89,705,325 | |
| 5 | INSM |
INSMED Inc
|
660,601 | $70,433,276 | |
| 6 | KRYS |
Krystal Biotech, Inc.
|
158,675 | $58,974,733 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
228,645 | $55,096,584 | |
| 8 | EXEL |
Exelixis, Inc.
|
941,571 | $51,230,875 |
All Filings in TRVI
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,038,752 | 1,610,657 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $932,500 | 50,000 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $20,137,563 | 1,687,977 | Shares | Defined | 2026-05-14 | |
| 2026-03-31 | $1,193,000 | 100,000 | Call | Defined | 2026-05-14 | |
| 2025-12-31 | $1,878,000 | 150,000 | Call | Defined | 2026-02-18 | |
| 2025-12-31 | $22,122,375 | 1,766,963 | Shares | Defined | 2026-02-18 | |
| 2025-09-30 | $12,910,987 | 1,411,037 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,889,455 | 1,076,683 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,203,992 | 509,379 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $49,440 | 12,000 | Shares | Defined | 2025-04-23 | |
| No filing history on record for this holder in this stock. | ||||||